Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

6,679 studies for “New York”

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)Recruiting
NCT05564390Phase 2Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Acute Myeloid Leukemia · Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm · Acute Myeloid Leukemia Post Cytotoxic Therapy · Acute Myeloid Leukemia, Myelodysplasia-Related
United States, Canada, Puerto Rico
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)Recruiting
NCT06024746Phase 3Updated Sep 10, 2026
Sponsor: Colorado Prevention Center
Heart Failure
United States, Brazil, Canada, China, India +3 more
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCCRecruiting
NCT07462377Phase 1Updated Sep 10, 2026
Sponsor: EpiBiologics
Epidermal Growth Factor · Epidermal Growth Factor Receptor · Epidermal Growth Factor Receptor Gene Mutation · Non Small Cell
United States
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or CarcinosarcomaRecruiting
NCT05256225Phase 3Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Endometrial Carcinoma · Endometrial Clear Cell Adenocarcinoma · Endometrial Dedifferentiated Carcinoma · Endometrial Endometrioid Adenocarcinoma
United States, Puerto Rico, South Korea
Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY)Active Not Recruiting
NCT05051033NAUpdated Sep 10, 2026
Sponsor: Annetine Gelijns
Mitral Valve Regurgitation
United States, Canada, Germany, Spain, United Kingdom
CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)Recruiting
NCT06708299Phase 3Updated Sep 10, 2026
Sponsor: Cardiol Therapeutics Inc.
Recurrent Pericarditis
United States, Canada, Greece, Italy
BPL-003 Efficacy and Safety in Treatment Resistant DepressionCompleted
NCT05870540Phase 2Updated Sep 10, 2026
Sponsor: Beckley Psytech Limited
Treatment Resistant Depression
United States, Australia, Germany, Poland, Spain +1 more
Comparing the Addition of Radiation Either Before or After Surgery for Patients With Brain MetastasesActive Not Recruiting
NCT05438212Phase 3Updated Sep 10, 2026
Sponsor: NRG Oncology
Metastatic Malignant Neoplasm in the Brain
United States, Canada, Japan
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary TumorsRecruiting
NCT03866382Phase 2Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Bladder Adenocarcinoma · Bladder Clear Cell Adenocarcinoma · Bladder Mixed Adenocarcinoma · Bladder Neuroendocrine Carcinoma
United States, Puerto Rico
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal CancerActive Not Recruiting
NCT03233711Phase 3Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Anal Basaloid Carcinoma · Anal Canal Cloacogenic Carcinoma · Anal Margin Squamous Cell Carcinoma · Stage IIB Anal Cancer AJCC v8
United States, Canada
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade GliomaRecruiting
NCT04166409Phase 3Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Low Grade Astrocytoma · Low Grade Glioma · Metastatic Low Grade Astrocytoma · Metastatic Low Grade Glioma
United States, Canada, Puerto Rico
A Study to Compare Chemotherapy Alone Versus Chemotherapy Plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Therapy After Surgery With Nivolumab or Nivolumab and BMS-986205 in Participants With Muscle Invasive Bladder CancerCompleted
NCT03661320Phase 3Updated Sep 10, 2026
Sponsor: Bristol-Myers Squibb
Urinary Bladder Neoplasms · Muscle-Invasive Bladder Cancer
United States, Argentina, Australia, Austria, Belgium +23 more
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung CancerRecruiting
NCT04181060Phase 3Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Advanced Lung Non-Squamous Non-Small Cell Carcinoma · Metastatic Lung Non-Squamous Non-Small Cell Carcinoma · Recurrent Lung Non-Squamous Non-Small Cell Carcinoma · Stage IIIB Lung Cancer AJCC v8
United States
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)Recruiting
NCT06124157Phase 2Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
B Acute Lymphoblastic Leukemia
United States, Australia, Canada, Puerto Rico
Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung CancerActive Not Recruiting
NCT04310007Phase 2Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Metastatic Lung Non-Squamous Non-Small Cell Carcinoma · Recurrent Lung Non-Squamous Non-Small Cell Carcinoma · Stage IV Lung Cancer AJCC v8
United States
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening TrialRecruiting
NCT05564377Phase 2Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Advanced Malignant Solid Neoplasm · Anatomic Stage III Breast Cancer AJCC v8 · Anatomic Stage IV Breast Cancer AJCC v8 · Locally Advanced Malignant Solid Neoplasm
United States, Puerto Rico
A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent.Active Not Recruiting
NCT05109728Phase 1Updated Sep 10, 2026
Sponsor: Novartis Pharmaceuticals
Glioblastoma
United States, France, Portugal, Spain, Switzerland
Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and EtoposideCompleted
NCT00632853Phase 3Updated Sep 10, 2026
Sponsor: Alliance for Clinical Trials in Oncology
Lung Cancer
United States, Israel, Puerto Rico, South Korea
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by SurgeryRecruiting
NCT03180268Phase 3Updated Sep 10, 2026
Sponsor: NRG Oncology
Grade 2 Meningioma · Intracranial Meningioma
United States, Canada, India, Japan, Saudi Arabia
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and NivolumabRecruiting
NCT05675410Phase 3Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
United States, Canada, Puerto Rico
Determination of the Optimal Treatment Target in Ulcerative ColitisCompleted
NCT04259138Phase 4Updated Sep 10, 2026
Sponsor: Alimentiv Inc.
Colitis, Ulcerative
United States, Belarus, Belgium, Canada, France +5 more
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)Recruiting
NCT06317649Phase 2Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Acute Myeloid Leukemia
United States, Puerto Rico
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid TumorsRecruiting
NCT06914128Phase 1, Phase 2Updated Sep 10, 2026
Sponsor: Bayer
MTAP-deleted Solid Tumors
United States, Australia, Belgium, China, Czechia +8 more
Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction CancerActive Not Recruiting
NCT01142388Phase 2Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Metastatic Esophageal Adenocarcinoma · Metastatic Esophageal Squamous Cell Carcinoma · Metastatic Gastroesophageal Junction Adenocarcinoma · Recurrent Esophageal Adenocarcinoma
United States
Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNAActive Not Recruiting
NCT02135042Phase 2, Phase 3Updated Sep 10, 2026
Sponsor: NRG Oncology
EBV Infection · Stage II Nasopharyngeal Carcinoma AJCC v7 · Stage III Nasopharyngeal Carcinoma AJCC v7 · Stage IVA Nasopharyngeal Carcinoma AJCC v7
United States, Australia, Canada, China, Hong Kong +3 more

6,679 studies found